Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pembrolizumab Induced Calcitriol-Mediated Hypercalcemia.

Case reports in nephrology·2023

Same author

Unique Presentation of Thyrotoxic Periodic Paralysis With Urticarial Dermographia.

Military medicine·2022

Same author

Unique Presentation of Septic Cavernous Sinus Thrombosis and Pulmonary Embolism in the Setting of Reusable Face Covering.

Case reports in infectious diseases·2022

Same author

Persons tested for SAR-CoV-2 at a military treatment facility in Hawaii.

PloS one·2022

Same author

Ocular manifestation in gout: an unusual presentation of gout.

Clinical rheumatology·2022

Same author

Segmental arterial mediolysis: differentiation of rare arteriopathy from vascular mimics.

BMJ case reports·2021

Search research articles

Related Experiment Video

Updated: Sep 6, 2025

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

Ectopic Cavernous Sinus Microprolactinoma Treated Medically.

Robert M Minns¹, Javier Barranco-Trabi¹, Alvin C Yiu¹

¹Department of Medicine, Tripler Army Medical Center, Honolulu, Hi 96859, USA.

Military Medicine

|June 27, 2022

Summary

This summary is machine-generated.

Ectopic prolactin-secreting microadenomas, though rare, can be effectively managed with cabergoline medication. This case demonstrates successful treatment of a dopamine-resistant ectopic microprolactinoma, leading to symptom resolution and tumor reduction.

More Related Videos

Surgical Treatment of an Endolymphatic Sac Tumor

Surgical Treatment of an Endolymphatic Sac Tumor

Published on: May 26, 2023

Author Spotlight: A Single-Entry Point Endoscopic Intraventricular Approach for Third Ventriculostomy and Pineal Biopsy

Author Spotlight: A Single-Entry Point Endoscopic Intraventricular Approach for Third Ventriculostomy and Pineal Biopsy

Published on: June 28, 2024

Related Experiment Videos

Last Updated: Sep 6, 2025

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

Surgical Treatment of an Endolymphatic Sac Tumor

Surgical Treatment of an Endolymphatic Sac Tumor

Published on: May 26, 2023

Author Spotlight: A Single-Entry Point Endoscopic Intraventricular Approach for Third Ventriculostomy and Pineal Biopsy

Author Spotlight: A Single-Entry Point Endoscopic Intraventricular Approach for Third Ventriculostomy and Pineal Biopsy

Published on: June 28, 2024

Area of Science:

Endocrinology
Neurosurgery
Oncology

Background:

Ectopic prolactin-secreting microadenomas are rare pituitary tumors.
Management typically involves surgery, unlike common intrasellar prolactinomas.

Observation:

A 30-year-old male presented with erectile dysfunction and elevated prolactin levels.
Pituitary MRI revealed a 9mm microadenoma in the left cavernous sinus.

Findings:

Treatment with cabergoline, even at high doses, resolved symptoms and normalized prolactin levels.
The ectopic microprolactinoma showed significant size reduction and cystic degeneration.

Implications:

Medical management with cabergoline can be a successful alternative to surgery for ectopic prolactinomas.
This approach is effective even in cases of dopamine resistance, offering a less invasive treatment option.